13F-HR filed by BROADWOOD CAPITAL INC
BROADWOOD CAPITAL INC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 7 holding rows worth $1,195,552,364.
- Accession
- 0000919574-23-001165
- Filer
- CIK 1278387
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 7 entries on the cover page, a total value of $1,195,552,364 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,195,552,363 with VALUE read as dollars as filed, 13F file number 028-13773. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerBROADWOOD PARTNERS, L.P.028-13770
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MONSTER BEVERAGE CORP NEW COM | 61174X109 | Stock | 4,656,488 | $472,773,227 | dollars as filed | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 8,783,082 | $426,330,800 | dollars as filed | |
| AXONENTERPRISEINC | 05464C101 | STOK | 760,062 | $126,117,088 | dollars as filed | |
| iShares Russell 2000 ETF | 464287655 | SHS | 690,000 | $120,308,400 | dollars as filed | |
| LINEAGE CELL THERAPEUTICS IN | 53566P109 | COMMON STOCK | 34,935,485 | $40,874,517 | dollars as filed | |
| ONCOCYTE CORP | 68235C107 | COM | 23,353,697 | $7,494,201 | dollars as filed | |
| AGEX THERAPEUTICS INC | 00848H108 | COM | 2,997,156 | $1,654,130 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-23-001165 | this filing | 2023-02-14 | acceptance time not in the bulk data set |